WeVote
Log In

Bill

Bill

A 1084

Establishes the fentanyl and xylazine test strip program

2025 Regular Session Introduced by Alex Bores and 3 co-sponsors

Bill A 1084 establishes a program providing fentanyl and xylazine test strips to drug users, aiming to reduce overdose deaths and promote safer drug use practices.

ENACTING CLAUSE STRICKEN
0
WeVote Research Nonpartisan
Bill Summary · A 1084

Summary of Bill A 1084: Establishes the Fentanyl and Xylazine Test Strip Program

Purpose and Intent

Bill A 1084 aims to address the growing public health crisis related to substance use, specifically targeting the dangers posed by fentanyl and xylazine. The bill seeks to establish a program that provides test strips for these substances, enabling individuals to test their drugs for the presence of harmful additives. This initiative is intended to reduce overdose deaths and promote safer drug use practices.

Key Provisions

  • Test Strip Program: The bill establishes a program to distribute fentanyl and xylazine test strips to individuals at risk of substance use. These strips will allow users to check for the presence of these potent and often lethal substances in their drugs.

  • Education and Outreach: The program will include educational components to inform users about the risks associated with fentanyl and xylazine, as well as how to properly use the test strips.

  • Partnerships: The bill encourages collaboration with local health departments, community organizations, and harm reduction groups to facilitate the distribution and education efforts.

  • Funding: While specific funding amounts are not detailed in the bill, it is anticipated that financial resources will be allocated to support the implementation of the program.

Affected Parties

  • Individuals at Risk: The primary beneficiaries of this program will be individuals who use drugs and are at risk of exposure to fentanyl and xylazine.

  • Health Organizations: Local health departments and community organizations involved in substance use prevention and harm reduction will play a crucial role in the program's implementation.

  • Public Health: The broader community may benefit from reduced overdose rates and improved public health outcomes as a result of increased awareness and safer practices.

Procedural Timeline

  • Introduced: January 08, 2025
  • Referred to Committees: Initially referred to the Committee on Alcoholism and Drug Abuse, the bill was reported and subsequently referred to the Committee on Ways and Means on May 19, 2025.

Related Legislation

  • A 5005: This bill is related to prior legislative efforts aimed at addressing substance use and overdose prevention, indicating a continued focus on these critical public health issues.

Conclusion

Bill A 1084 represents a proactive approach to mitigating the risks associated with fentanyl and xylazine use. By establishing a test strip program, the bill aims to empower individuals with the tools necessary to make safer choices, ultimately contributing to the reduction of overdose fatalities in the community. The ongoing legislative process will determine the final structure and funding of the program.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.